Alivus Life Sciences Ltd header image

Alivus Life Sciences Ltd

543322

Equity

ISIN INE03Q201024 / Valor 112824626

Bombay Stock Exchange Ltd. (Mumbai) (2026-09-07)
INR 1,386.75+1.45%

Alivus Life Sciences Ltd
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Alivus Life Sciences Ltd is a life‑sciences company focused on developing and bringing biomedical technologies and services to the healthcare market. Its operations typically span early‑stage research and development through productization, with activities that can include preclinical and clinical programs, diagnostic or therapeutic product development, and provision of research or manufacturing services to partners. The company’s commercial strategy is built around developing proprietary intellectual property, pursuing necessary regulatory clearances, and generating revenue through product sales, service contracts and strategic collaborations or licensing agreements to scale distribution into clinical, laboratory and specialist care channels.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

50.4%1Y
120%3Y
107%5Y

Performance

29.5%1Y
35.8%3Y
32.5%5Y

Volatility

Market cap

1796 M

Market cap (USD)

Daily traded volume (Shares)

8,100

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Attendo AB
Attendo AB Attendo AB Valor: 30491576
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.41%SEK 122.00
Hims & Hers Health Inc
Hims & Hers Health Inc Hims & Hers Health Inc Valor: 59397181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.40%USD 27.71
Venture Life Group PLC
Venture Life Group PLC Venture Life Group PLC Valor: 23084203
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.45%GBP 0.67
Arvinas Inc
Arvinas Inc Arvinas Inc Valor: 43526042
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.86%USD 9.39
CG Oncology Inc
CG Oncology Inc CG Oncology Inc Valor: 131996952
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.46%USD 74.67
Lineage Inc
Lineage Inc Lineage Inc Valor: 136372357
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.42%USD 38.17
Geratherm Medical AG
Geratherm Medical AG Geratherm Medical AG Valor: 1091371
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.19%EUR 2.50
Medartis Holding AG
Medartis Holding AG Medartis Holding AG Valor: 38620023
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.11%CHF 88.00
DocMorris Ltd
DocMorris Ltd DocMorris Ltd Valor: 4261528
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.28%CHF 10.76
JB Chemicals & Pharmaceuticals Ltd.
JB Chemicals & Pharmaceuticals Ltd. JB Chemicals & Pharmaceuticals Ltd. Valor: 129355399
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%INR 2,412.25